You are here

Young Cho, PhD

School of Naturopathic Medicine
Department of Basic Sciences

Current Roles

Dr. Cho is a core faculty member in the Department of Basic Sciences at Bastyr University California.


  • PhD in pharmacology from University of Wisconsin Medical School
  • Beckman Fellowship from Beckman Research Institute of City of Hope
  • Bachelor of Arts in chemistry from Indiana University-Bloomington

Past Experience

Before transferring to Bastyr University California, Dr. Cho was a core faculty member in the Department of Basic Sciences at Bastyr University's Kenmore campus, where he taught a variety of undergraduate and graduate courses for students of naturopathic medicine, acupuncture and East Asian medicine, herbal sciences and nutrition.
Dr. Cho has conducted postdoctoral research as a team leader of endocrine drug discovery and physiologic impacts of the nuclear bile acid receptor on immune response. He has taught cell biology and human physiology at California State University.
Dr. Cho also has served as an advisor for student research. His research is focused on anti-adipogenic effects of natural bile acids as well as anti-tumorigenic effects of Chinese herbal extracts.

Classes Taught

Pharmacology, Pharmacology of Cancer, Pathology of Cancer, Biochemistry, Organic Chemistry and Disease Processes.


Dr. Cho’s research topics include physiological effects of bile acids on fibroblastic transformation into fat cells. He has screened pro-adipogenic and anti-adipogenic bile acids using cellular model systems in order to examine clinical application in obesity cases. In addition, Dr. Cho is working on cytotoxic and cytostatic actions of various Chinese plant extracts in human cancer cells.


Dr. Cho believes that good health care is more than medicine. His philosophy of teaching and research is to integrate the basic medical sciences with holistic health care.

Current Research

Anti-Cancer Actions of Bai Tu Weng (BT), Chinese Herbal Extract

The aim of this study is analyze the genomic action of BT on tumor promoter and suppression genes in MDA-MB-231 mammary carcinoma cell line in a mid- or long-term range. Integrate genomic and non-genomic actions of anti-neoplastic BT agent on mammary carcinoma cell-line.

Gene regulation of tumor promoter and suppressor genes is involved in the most invasive MDA-MB-231 cells when BT induces cell cycle arrest by blocking signal transduction pathways at the level of MAPK as well as PI3K. Cellular mRNA during treatment with BT will be reverse-transcribed into cDNA library. First, major target genes involved in tumor suppression as well as promotion will be probed by Real Time-PCR. Second, comprehensive gene regulation by BT will be analyzed by the microarray analysis. This proposal may integrate the anti-neoplastic and cytostatic action of BT via non-genomic as well as genomic level before the follow-up in vivo (clinical) trial.


Young Cho, PhD
Young Cho, PhD